ValuEngine upgraded shares of CRISPR Therapeutics (NASDAQ:CRSP) from a sell rating to a hold rating in a research note issued to investors on Monday, April 2nd. A number of other research analysts have also recently weighed in on the stock. Piper Jaffray reaffirmed a buy rating and set a $22.75 price target (down from $39.00) […]

The oceans are under attack and all signs point toward humans as the perpetrators. Sea temperatures are rising, fish populations are dwindling, and coral reefs are experiencing an unprecedented die-off called bleaching. For most accounts, the future for plants and animals on Earth looks pretty grim. One could argue that rampant advances in technology are […]

  Two former engineers of SpaceX, Paul, and Michael Dabrowski, are now collaborating with scientists to find a cure for genetic diseases. Synthego is willing enough to help scientists with the utilization of CRISPR to edit genetic code. According to them, CRISPR is a biological breakthrough that will enable scientists to discover cures for usual […]

VeriSign, Inc. (NASDAQ:VRSN) shares are up more than 3.11% this year and recently decreased -4.75% or -$5.88 to settle at $118.00. CRISPR Therapeutics AG (NASDAQ:CRSP), on the other hand, is up 101.32% year to date as of 04/24/2018. It currently trades at $47.27 and has returned -10.35% during the past week. VeriSign, Inc. (NASDAQ:VRSN) and […]

Credit: CC0 Public Domain Would we be wise to prioritize “shovel-ready” science over curiosity-driven, fundamental research programs? Would that set the stage for the discovery of more new medicines over the long term? To find solid answers to these questions, scientists at Harvard and the Novartis Institute for Biomedical Research (NIBR), publishing in Science Translational […]

Global CRISPR market is anticipated to grow at a CAGR of +35% During Forecast Period CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is an RNA-induced gene editing system that uses bacterial-derived proteins (Cas9) and synthetic inducible RNA to introduce double-strand breaks at specific locations within the genome. Through this method, bacteria capture short nucleic acid […]

The answers to the following key questions are answered in this report: How did the CRISPR technology market evolve, and what is its scope in the future? What are the major market drivers, challenges and opportunities in the global CRISPR technology market? What are the key developmental strategies that are being implemented by the key […]

On Tuesday, Skechers U.S.A., Inc. (NYSE:SKX) reached at $29.21 price level during last trade its distance from 20 days simple moving average is -26.06%, and its distance from 50 days simple moving average is -26.83% while it has a distance of -13.29% from the 200 days simple moving average. The company’s distance from 52-week high […]

ValuEngine upgraded shares of CRISPR Therapeutics (NASDAQ:CRSP) from a sell rating to a hold rating in a research note issued to investors on Monday, April 2nd. Other analysts have also issued research reports about the stock. Zacks Investment Research raised shares of CRISPR Therapeutics from a sell rating to a hold rating in a report […]